Dova Pharma Reports Second Quarter 2017 Operating and Financial Results Post author:Sam Post published:August 10, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017 Axovant Strengthens Executive Team With Key Management Appointments June 5, 2017 Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017
Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017
Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017